CopyPastehas never been so tasty!

The Pharmaceutical Market : Indonesia

by anonymous

  • 0
  • 0
  • 0
56 views

OVERVIEW OF THE PHARMACEUTICAL MARKET IN INDONESIA

Environmentally, Indonesia is particularly prone to natural disasters, as the recent earthquakes, tsunamis and volcanic eruptions have illustrated. Politically, a dominant feature of President Yudhoyono’s presidency has been to curb the corruption that has so frequently plagued Indonesia. Economically, Indonesia’s economy is projected to become the sixth largest in the Asia Pacific region by 2017, but if the rupiah continues to devaluate against the dollar it could affect the Indonesian pharmaceutical market in US dollar terms. Legally, Indonesia remained on the USTR’s Special 301 Priority Watch List in 2011, due to the prevalence of counterfeit pharmaceuticals. Demographically, the population will be the third largest in the Asia Pacific region by 2017. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/the-pharmaceutical-market-indonesia.html

The Indonesian Pharmaceutical Manufacturers Association (GP Farmasi) announced that 20 of its members had increased the price of certain drugs by up to 10.0%, at the start of the 2011. Members of GP Farmasi have raised their drug prices in response to rising inflation, a decision by regional authorities to increase the minimum wage and an import tax imposed on raw materials for drug manufacturing. In February 2011, the Ministry of Health announced that it would review the prices of generic drugs, in light of the fact that the increase in tax on raw materials has prompted pharmaceutical companies to raise the prices of branded drugs. Many pharmaceutical companies have stated that, in their view, the prices of generic drugs are unreasonably low.

Due to the sheer size of the population, Indonesia cannot simply be dismissed. The Indonesian pharmaceutical market is projected to grow at a high single-digit CAGR in US dollar terms during the forecast period, and it will be the sixth largest pharmaceutical market in the Asia Pacific region by 2017. In 2010, there were around 250 pharmaceutical manufacturers, with the vast majority located in Java. However, despite the country possessing huge manufacturing capabilities, the complete lack of R&D in local companies could affect the market, especially if IPR regulations were tightened. Although multinationals will be unhappy at the legislation requiring all drugs in the Indonesian market to have been manufactured in Indonesia, it could potentially reduce costs in the long term for both the manufacturer and the consumer.

PROVIDING STRATEGIC MARKET ANALYSIS EVERY MONTH
Espicom's highly-regarded world pharmaceutical market research reports provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Market size and trends impacting the development of the market.
Five-year projections for market indicators such as health spending.
Regulations on drug applications & approvals, pricing & reimbursement as well as wholesaling and retail.
Specialised intelligence on generics and biological medicines.
Foreign and local company profiles

EXECUTIVE SUMMARY. 1
Snapshot: Strategic Espicom Analysis..2
Snapshot: Key Data Projections..3
MACROENVIRONMENT .... 4
POLITICAL4
ECONOMIC...5
Projections...5
LEGAL..6
DEMOGRAPHIC7
Projections...7
Demographic Indicators.8
Births.... 8
Deaths. 8
Infant Deaths 8
Life Expectancy at Birth. 8
EPIDEMIOLOGY.. 9
DISEASE BURDEN..9
Leading Causes of Mortality9
DISEASE PREVALENCE....9
Communicable Diseases.9
HIV/AIDS... 9
Non-communicable Diseases.10
Diabetes. 10
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS....11
ORGANISATION...11
New Health Insurance Programme for the Poor - Jamkesmas 11
Corruption Rife in Health Sector.12
EXPENDITURE.12
Projections.12
INFRASTRUCTURE....13
Inpatient Infrastructure13
Infrastructure Developments.... 13
Outpatient Infrastructure..13
SERVICES14
Inpatient Analysis14
Cancer 14
Outpatient Analysis.15
WORKFORCE...15
Projections.15
Current State...16
Government to Address Shortage of Physicians in Remote Regions 16
REGULATORY AFFAIRS... 17
INTERNATIONAL AUTHORITY....17
NATIONAL AUTHORITY17
REGULATORY DEVELOPMENTS.18
GOOD MANUFACTURING PRACTICE...18
MARKETING REGISTRATION..19
Approval Times....19
DRUG LABELLING.... 20
PROMOTION.. 20
Advertising.20
PRICING & REIMBURSEMENT... 21
Essential Drugs List..21
DISTRIBUTION CHANNELS.. 22
DRUG WHOLESALING.. 22
Selected Wholesalers....22
Anugerah Pharmindo Lestari (APL)....22
Enseval...22
Lautan Luas23
Millennium Pharmacon International (MPI)23
Parit Padang....23
Zuellig Pharma23
DRUG RETAILING.24
Selected Pharmacy Chains25
Apotek K-2425
Century Healthcare..25
Kimia Farma Apotek25
Watsons..25
MARKET ANALYSIS 26
SIZE....26
Projections.26
Latest Figures..27
Historical Figures.28
PRODUCT DEVELOPMENT.... 29
MANUFACTURING... 29
TRADE... 30
Exports..30
Imports..33
Balance of Trade..37
COMPETITION... 38
TRADE ASSOCIATION... 38
IPMG...38
TRADE FAIRS...39
IndoMedica39
IPEX....39
COMPANY INTELLIGENCE 40
Multinational Manufacturers.40
Bayer Indonesia...40
Merck Tbk...40
Novartis Indonesia...40
Pfizer Indonesia...40
Sanofi. 41
OTC PHARMACEUTICALS 42
MARKET SIZE...42
COMPETITION.42
Company Intelligence...42
Darya-Varia Group... 42
Konimex.43
Soho Group43
Tempo Scan Pacific...43
GENERIC PHARMACEUTICALS.44
REGULATION.. 44
Approval44
People’s Pharmacy...44
MARKET SIZE.. 44
COMPETITION 44
Trade Association44
GP Farmasi..44
Company Intelligence...45
Combiphar..45
Dexa Medica ...45

For more information kindly visit :
The Pharmaceutical Market : Indonesia

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/

Add A Comment: